Published in PLoS One on May 24, 2012
At low pH, influenza virus matrix protein M1 undergoes a conformational change prior to dissociating from the membrane. J Virol (2013) 0.98
Stepwise priming by acidic pH and a high K+ concentration is required for efficient uncoating of influenza A virus cores after penetration. J Virol (2014) 0.94
Structural analysis of influenza A virus matrix protein M1 and its self-assemblies at low pH. PLoS One (2013) 0.87
Influenza A matrix protein M1 multimerizes upon binding to lipid membranes. Biophys J (2014) 0.82
Crystal structures of influenza A virus matrix protein M1: variations on a theme. PLoS One (2014) 0.81
pH-Dependent Formation and Disintegration of the Influenza A Virus Protein Scaffold To Provide Tension for Membrane Fusion. J Virol (2015) 0.79
Two polar residues within C-terminal domain of M1 are critical for the formation of influenza A Virions. Cell Microbiol (2015) 0.76
Mutations Designed by Ensemble Defect to Misfold Conserved RNA Structures of Influenza A Segments 7 and 8 Affect Splicing and Attenuate Viral Replication in Cell Culture. PLoS One (2016) 0.76
Involvement of an Arginine Triplet in M1 Matrix Protein Interaction with Membranes and in M1 Recruitment into Virus-Like Particles of the Influenza A(H1N1)pdm09 Virus. PLoS One (2016) 0.76
The Matrix protein M1 from influenza C virus induces tubular membrane invaginations in an in vitro cell membrane model. Sci Rep (2017) 0.75
Cell penetrable human scFv specific to middle domain of matrix protein-1 protects mice from lethal influenza. Viruses (2015) 0.75
Broad Spectrum Anti-Influenza Agents by Inhibiting Self-Association of Matrix Protein 1. Sci Rep (2016) 0.75
Ubiquitin in Influenza Virus Entry and Innate Immunity. Viruses (2016) 0.75
Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys J (2000) 21.93
Determination of molecular weights and frictional ratios of proteins in impure systems by use of gel filtration and density gradient centrifugation. Application to crude preparations of sulfite and hydroxylamine reductases. Biochim Biophys Acta (1966) 16.27
Influenza virus M2 protein has ion channel activity. Cell (1992) 8.52
Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol (2005) 5.28
Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature (2006) 4.52
The gene structure and replication of influenza virus. Annu Rev Biochem (1983) 4.30
The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J Gen Virol (2002) 3.77
Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins. J Virol (1991) 3.29
Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein. J Virol (2000) 2.94
Influenza virus assembly and budding. Virology (2011) 2.90
Assembly and budding of influenza virus. Virus Res (2004) 2.90
Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J Virol (2007) 2.82
The structure of influenza virus. II. A model based on the morphology and composition of subviral particles. Virology (1972) 2.60
The closed state of a H+ channel helical bundle combining precise orientational and distance restraints from solid state NMR. Biochemistry (2002) 2.56
Influenza virus matrix protein is the major driving force in virus budding. J Virol (2000) 2.49
Structure and mechanism of proton transport through the transmembrane tetrameric M2 protein bundle of the influenza A virus. Proc Natl Acad Sci U S A (2010) 2.43
Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the matrix protein. J Virol (1996) 2.30
The structure of a biologically active influenza virus ribonucleoprotein complex. PLoS Pathog (2009) 2.23
Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. J Virol (1996) 2.08
Influenza virus morphogenesis and budding. Virus Res (2009) 2.07
Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. J Virol (2001) 2.04
Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1. Nat Struct Biol (1997) 2.02
Cellular proteins in influenza virus particles. PLoS Pathog (2008) 1.96
Identification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions. J Gen Virol (2007) 1.83
Structural organization of a filamentous influenza A virus. Proc Natl Acad Sci U S A (2010) 1.81
Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins. J Virol (2000) 1.78
Influenza virus m2 ion channel protein is necessary for filamentous virion formation. J Virol (2010) 1.73
Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses. Virus Res (2003) 1.70
Membrane interaction of influenza virus M1 protein. Virology (2000) 1.63
The crystal structure of the influenza matrix protein M1 at neutral pH: M1-M1 protein interfaces can rotate in the oligomeric structures of M1. Virology (2001) 1.63
Transport of viral proteins to the apical membranes and interaction of matrix protein with glycoproteins in the assembly of influenza viruses. Virus Res (2001) 1.56
Association of influenza virus NP and M1 proteins with cellular cytoskeletal elements in influenza virus-infected cells. J Virol (1997) 1.54
Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization. J Virol (2006) 1.52
RNA-binding properties of influenza A virus matrix protein M1. Nucleic Acids Res (1989) 1.51
Fine structure of influenza A virus observed by electron cryo-microscopy. EMBO J (1994) 1.48
Isolation of matrix protein M1 from influenza viruses by acid-dependent extraction with nonionic detergent. Virology (1992) 1.47
Electron microscopy of the influenza virus submembranal structure. Virology (1989) 1.42
Cyclophilin A interacts with influenza A virus M1 protein and impairs the early stage of the viral replication. Cell Microbiol (2009) 1.40
Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription. J Virol (2010) 1.39
Death by influenza virus protein. Nat Med (2001) 1.36
Influenza virus M1 protein binds to RNA through its nuclear localization signal. J Gen Virol (1997) 1.31
Structural changes in Influenza virus at low pH characterized by cryo-electron tomography. J Virol (2012) 1.30
Combined results from solution studies on intact influenza virus M1 protein and from a new crystal form of its N-terminal domain show that M1 is an elongated monomer. Virology (2001) 1.29
Studies on the helical nucleocapsid of influenza virus. Virology (1982) 1.27
The lack of an inherent membrane targeting signal is responsible for the failure of the matrix (M1) protein of influenza A virus to bud into virus-like particles. J Virol (2010) 1.25
The M1 and NP proteins of influenza A virus form homo- but not heterooligomeric complexes when coexpressed in BHK-21 cells. J Gen Virol (1998) 1.20
The SUMOylation of matrix protein M1 modulates the assembly and morphogenesis of influenza A virus. J Virol (2011) 1.17
Transcription and replication of eight RNA segments of influenza virus. Virology (1985) 1.14
A small percentage of influenza virus M1 protein contains zinc but zinc does not influence in vitro M1-RNA interaction. J Gen Virol (1994) 1.09
Measles virus M and F proteins associate with detergent-resistant membrane fractions and promote formation of virus-like particles. J Gen Virol (2007) 1.06
Identification and characterization of a monoclonal antibody to an antigen expressed on activated macrophages. Proc Natl Acad Sci U S A (1984) 0.98
Vaccine potential of Nipah virus-like particles. PLoS One (2011) 0.97
The in situ spatial arrangement of the influenza A virus matrix protein M1 assessed by tritium bombardment. Proc Natl Acad Sci U S A (1999) 0.95
Role of G protein and protein kinase signalling in influenza virus budding in MDCK cells. J Gen Virol (2002) 0.88
Oligomerization and assembly of the matrix protein of Borna disease virus. FEBS Lett (2005) 0.84
Cyclophilin E functions as a negative regulator to influenza virus replication by impairing the formation of the viral ribonucleoprotein complex. PLoS One (2011) 0.83
Spatial structure peculiarities of influenza A virus matrix M1 protein in an acidic solution that simulates the internal lysosomal medium. FEBS J (2011) 0.81
[Disordered regions in C-domain structure of influenza virus M1 protein]. Mol Biol (Mosk) (2011) 0.80
The in situ structural characterization of the influenza A virus matrix M1 protein within a virion. Protein Pept Lett (2009) 0.79
Analytical ultracentrifugation. Curr Protoc Protein Sci (2001) 0.78
Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet (2013) 6.10
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell (2006) 4.15
The Arabidopsis CORONATINE INSENSITIVE1 protein is a jasmonate receptor. Plant Cell (2009) 3.31
Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res (2008) 2.97
The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α. Nat Med (2012) 2.66
Impact of land use and land cover changes on ecosystem services in Menglun, Xishuangbanna, Southwest China. Environ Monit Assess (2007) 2.61
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer. Proc Natl Acad Sci U S A (2007) 2.39
Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science (2013) 2.34
A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. Am J Pathol (2003) 2.28
Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin. Clin Cancer Res (2008) 2.27
The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. J Virol (2010) 1.94
CIP2A is associated with human breast cancer aggressivity. Clin Cancer Res (2009) 1.81
X-ray microbeam measurements of individual dislocation cell elastic strains in deformed single-crystal copper. Nat Mater (2006) 1.72
Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc Natl Acad Sci U S A (2009) 1.71
Lsr2 is a nucleoid-associated protein that targets AT-rich sequences and virulence genes in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2010) 1.61
Intravascular optical coherence tomography detection of atherosclerosis and inflammation in murine aorta. Arterioscler Thromb Vasc Biol (2012) 1.61
Identification of cancer genes using a statistical framework for multiexperiment analysis of nondiscretized array CGH data. Nucleic Acids Res (2008) 1.52
Characterization of two distinct neuraminidases from avian-origin human-infecting H7N9 influenza viruses. Cell Res (2013) 1.47
BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A. Breast Cancer Res (2009) 1.44
Revealing a natural marine product as a novel agonist for retinoic acid receptors with a unique binding mode and inhibitory effects on cancer cells. Biochem J (2012) 1.44
Periplasmic protein HdeA exhibits chaperone-like activity exclusively within stomach pH range by transforming into disordered conformation. J Biol Chem (2005) 1.42
F gene recombination between genotype II and VII Newcastle disease virus. Virus Res (2007) 1.42
Cyclophilin A interacts with influenza A virus M1 protein and impairs the early stage of the viral replication. Cell Microbiol (2009) 1.40
Shotgun proteomic analysis of sarcoplasmic reticulum preparations from rabbit skeletal muscle. Proteomics (2013) 1.40
Gossypol induces Bax/Bak-independent activation of apoptosis and cytochrome c release via a conformational change in Bcl-2. FASEB J (2006) 1.40
Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion. J Virol (2012) 1.36
Monitoring autophagic flux by an improved tandem fluorescent-tagged LC3 (mTagRFP-mWasabi-LC3) reveals that high-dose rapamycin impairs autophagic flux in cancer cells. Autophagy (2012) 1.32
Automics: an integrated platform for NMR-based metabonomics spectral processing and data analysis. BMC Bioinformatics (2009) 1.31
Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis. Biochem Biophys Res Commun (2006) 1.28
A nuclear export signal in the matrix protein of Influenza A virus is required for efficient virus replication. J Virol (2012) 1.28
Discovery of 4-substituted methoxybenzoyl-aryl-thiazole as novel anticancer agents: synthesis, biological evaluation, and structure-activity relationships. J Med Chem (2009) 1.27
Structural basis for recognition of AT-rich DNA by unrelated xenogeneic silencing proteins. Proc Natl Acad Sci U S A (2011) 1.26
Synaptotagmin C2B domain regulates Ca2+-triggered fusion in vitro: critical residues revealed by scanning alanine mutagenesis. J Biol Chem (2008) 1.25
Discovery of novel 2-aryl-4-benzoyl-imidazoles targeting the colchicines binding site in tubulin as potential anticancer agents. J Med Chem (2010) 1.21
Structural insight into poplar glutaredoxin C1 with a bridging iron-sulfur cluster at the active site. Biochemistry (2006) 1.21
Mechanism and function of synaptotagmin-mediated membrane apposition. Nat Struct Mol Biol (2011) 1.19
Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection. Microbes Infect (2002) 1.19
Further evidence for BRCA1 communication with the inactive X chromosome. Cell (2007) 1.15
Beclin 1-independent autophagy induced by a Bcl-XL/Bcl-2 targeting compound, Z18. Autophagy (2010) 1.15
Volumetric quantification of fibrous caps using intravascular optical coherence tomography. Biomed Opt Express (2012) 1.15
Silencing of foreign DNA in bacteria. Curr Opin Microbiol (2012) 1.12
Novel genetic reassortants in H9N2 influenza A viruses and their diverse pathogenicity to mice. Virol J (2011) 1.12
Conserved regulatory elements in AMPK. Nature (2013) 1.11
SIRT1 acts as a modulator of neointima formation following vascular injury in mice. Circ Res (2011) 1.11
Solution NMR structure of the TatA component of the twin-arginine protein transport system from gram-positive bacterium Bacillus subtilis. J Am Chem Soc (2010) 1.10
Antioxidant activities of oleanolic acid in vitro: possible role of Nrf2 and MAP kinases. Chem Biol Interact (2010) 1.09
Design, synthesis, and SAR studies of 4-substituted methoxylbenzoyl-aryl-thiazoles analogues as potent and orally bioavailable anticancer agents. J Med Chem (2011) 1.09
An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease. Exp Hematol (2004) 1.08
Metabolites of cerebellar neurons and hippocampal neurons play opposite roles in pathogenesis of Alzheimer's disease. PLoS One (2009) 1.07
Interspecies transmission and host restriction of avian H5N1 influenza virus. Sci China C Life Sci (2009) 1.07
Purified mouse CYP27B1 can hydroxylate 20,23-dihydroxyvitamin D3, producing 1alpha,20,23-trihydroxyvitamin D3, which has altered biological activity. Drug Metab Dispos (2010) 1.07
Purifying natively folded proteins from inclusion bodies using sarkosyl, Triton X-100, and CHAPS. Biotechniques (2010) 1.06
Identification and characterization of the dominant lactic acid bacteria from kurut: the naturally fermented yak milk in Qinghai, China. J Gen Appl Microbiol (2010) 1.06
Real-time polymerase chain reaction microRNA detection based on enzymatic stem-loop probes ligation. Anal Chem (2009) 1.06
West Nile virus-induced cytoplasmic membrane structures provide partial protection against the interferon-induced antiviral MxA protein. J Gen Virol (2007) 1.05
Hollow urchin-like ZnO thin films by electrochemical deposition. Adv Mater (2010) 1.05
An examination of the electrostatic interactions between the N-terminal tail of the Brome Mosaic Virus coat protein and encapsidated RNAs. J Mol Biol (2012) 1.04
Benzyl (E)-3-(4-meth-oxy-benzyl-idene)dithio-carbazate. Acta Crystallogr Sect E Struct Rep Online (2011) 1.04
Medroxyprogesterone acetate, but not progesterone, protects against inflammation-induced parturition and intrauterine fetal demise. Am J Obstet Gynecol (2004) 1.04
Membrane penetration by synaptotagmin is required for coupling calcium binding to vesicle fusion in vivo. J Neurosci (2011) 1.04
Virulence determinants between New York 99 and Kunjin strains of West Nile virus. Virology (2011) 1.04
Benzyl (E)-3-(2-methyl-benzyl-idene)dithio-carbazate. Acta Crystallogr Sect E Struct Rep Online (2011) 1.02
Identification and characterization of a biomineralization related gene PFMG1 highly expressed in the mantle of Pinctada fucata. Biochemistry (2007) 1.02
Cytokine and chemokine mRNA produced in synovial tissue chronically infected with Chlamydia trachomatis and C. pneumoniae. J Rheumatol (2002) 1.02
Pharmacokinetics, pharmacodynamics, and safety of tolvaptan, a nonpeptide AVP antagonist, during ascending single-dose studies in healthy subjects. J Clin Pharmacol (2007) 1.02
A novel Bcl-XL inhibitor Z36 that induces autophagic cell death in Hela cells. Autophagy (2009) 1.02
(-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis. World J Gastroenterol (2007) 1.01
Dominant-negative but not gain-of-function effects of a p53.R270H mutation in mouse epithelium tissue after DNA damage. Cancer Res (2007) 1.01
Diosgenin induces cell cycle arrest and apoptosis in human leukemia K562 cells with the disruption of Ca2+ homeostasis. Cancer Chemother Pharmacol (2004) 1.01
Synthesis, in vitro structure-activity relationship, and in vivo studies of 2-arylthiazolidine-4-carboxylic acid amides as anticancer agents. Bioorg Med Chem (2009) 1.01
[Review in the studies on tannins activity of cancer prevention and anticancer]. Zhong Yao Cai (2003) 1.00
X-ray micro-beam characterization of lattice rotations and distortions due to an individual dislocation. Nat Commun (2013) 0.99
Calcium binding by synaptotagmin's C2A domain is an essential element of the electrostatic switch that triggers synchronous synaptic transmission. J Neurosci (2012) 0.99
Correction of rotational distortion for catheter-based en face OCT and OCT angiography. Opt Lett (2014) 0.99
Synthesis and antiproliferative activity of novel 2-aryl-4-benzoyl-imidazole derivatives targeting tubulin polymerization. Bioorg Med Chem (2011) 0.99
MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10). J Biol Chem (2013) 0.99
Release mode of large and small dense-core vesicles specified by different synaptotagmin isoforms in PC12 cells. Mol Biol Cell (2011) 0.98
Heat shock protein 70 inhibits the activity of Influenza A virus ribonucleoprotein and blocks the replication of virus in vitro and in vivo. PLoS One (2011) 0.98
Motion artifacts associated with in vivo endoscopic OCT images of the esophagus. Opt Express (2011) 0.98
Structure-activity relationship studies of arylthiazolidine amides as selective cytotoxic agents for melanoma. Anticancer Res (2007) 0.97
PPARgamma transcriptionally regulates the expression of insulin-degrading enzyme in primary neurons. Biochem Biophys Res Commun (2009) 0.97
A role of histone H3 lysine 4 methyltransferase components in endosomal trafficking. J Cell Biol (2009) 0.97
Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers. BMC Cancer (2010) 0.97
Synthesis and antiproliferative activity of thiazolidine analogs for melanoma. Bioorg Med Chem Lett (2007) 0.96
Apoptosis induced by dioscin in Hela cells. Biol Pharm Bull (2002) 0.96
The solution structure of Escherichia coli Wzb reveals a novel substrate recognition mechanism of prokaryotic low molecular weight protein-tyrosine phosphatases. J Biol Chem (2006) 0.95
Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis. Carcinogenesis (2013) 0.95
A new mouse model for intraportal islet transplantation with limited hepatic lobe as a graft site. Transplantation (2006) 0.95
Mitochondrial dysfunction as an early event in the process of apoptosis induced by woodfordin I in human leukemia K562 cells. Toxicol Appl Pharmacol (2004) 0.95
Quantitative analysis of zeptomole microRNAs based on isothermal ramification amplification. RNA (2009) 0.95
A novel approach for lie detection based on F-score and extreme learning machine. PLoS One (2013) 0.95
Synaptotagmin 7 functions as a Ca2+-sensor for synaptic vesicle replenishment. Elife (2014) 0.95
Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications. J Hepatol (2010) 0.95
Conformational fluctuations coupled to the thiol-disulfide transfer between thioredoxin and arsenate reductase in Bacillus subtilis. J Biol Chem (2007) 0.95
Enhanced atherosclerosis in TIPE2-deficient mice is associated with increased macrophage responses to oxidized low-density lipoprotein. J Immunol (2013) 0.95
Noninvasive intraocular pressure measurements in mice by pneumotonometry. Invest Ophthalmol Vis Sci (2005) 0.95
Synthesis and antiproliferative activity of imidazole and imidazoline analogs for melanoma. Bioorg Med Chem Lett (2008) 0.95
miR-764-5p promotes osteoblast differentiation through inhibition of CHIP/STUB1 expression. J Bone Miner Res (2012) 0.94
Biological activity of 4-substituted methoxybenzoyl-aryl-thiazole: an active microtubule inhibitor. Cancer Res (2010) 0.94